SCHEMBL1042005

SCHEMBL1042005

Fc1cc(Cl)c(F)c(F)c1F

nearest known ligand 0.32

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 2/20 0.32
KDM1B Q8NB78 1/20 0.32
CES2 O00748 1/20 0.32
CES1 P23141 1/20 0.32
ALDH1A1 P00352 1/20 0.31
TDP1 Q9NUW8 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8528070 0.83 CYP3A4 (0.41) ALDH1A1
SCHEMBL7939692 0.80
SCHEMBL1756490 0.79 CYP3A4 (0.40) KDM1AKDM1BCES2CES1ALDH1A1
SCHEMBL11192387 0.79 GRIN2D (0.39) KDM1AKDM1BALDH1A1TDP1
SCHEMBL41646 0.75 CA1 (0.43) CES2CES1ALDH1A1
SCHEMBL7702552 0.75 CA1 (0.43) CES2CES1ALDH1A1
SCHEMBL24610552 0.75 POLB (0.35)
SCHEMBL18167032 0.75
SCHEMBL5386141 0.75 HDAC1 (0.35)
SCHEMBL8571604 0.75 HSD17B10 (0.39) ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1362860-B1 Method for producing tetrakis (fluoraryl)borate magnesium compound NIPPON CATALYTIC CHEM IND (JP) 2010-09-15 EP claimed
US-7205441-B2 Method for producing tetrakis (fluoroaryl) borate-magnesium compound NIPPON SHOKUBAI CO., LTD. (JP) 2007-04-17 US claimed
US-20030216598-A1 Method for producing tetrakis ( fluoroaryl) borate-magnesium compound NIPPON SHOKUBAI CO., LTD. (JP) 2003-11-20 US claimed
EP-1362860-A1 Method for producing tetrakis (fluoroaryl) borate magnesium compound Nippon Shokubai Co., Ltd. (JP) 2003-11-19 EP claimed
US-20230265055-A1 STAT INIHIBITORY COMPOUNDS AND COMPOSITIONS OXFORD FINANCE LLC 2023-08-24 US disclosed
WO-2022051639-A1 STAT INHIBITORY COMPOUNDS AND COMPOSITIONS JANPIX LIMITED (US) 2022-03-10 WO disclosed
CN-112368255-A Preparation method of halogenated polyfluorobenzene 谢尔盖·米哈伊洛维奇·伊古诺夫 2021-02-12 CN disclosed
EP-1955990-B1 PROCESS FOR PRODUCTION OF BIPHENYL DERIVATIVES TORAY FINECHEMICALS CO LTD (JP) 2012-08-22 EP disclosed
CN-101296889-B Process for production of biphenyl derivatives TORAY FINECHEMICALS CO LTD 2012-07-18 CN disclosed
CN-102531831-A Preparation method for 1-chlorin-2,3,4,5-phenyl tetrafluoride SHANGHAI SINOFLUORO SCIENT CO 2012-07-04 CN disclosed
US-7943257-B2 Electrolyte solvent and rechargeable lithium battery SAMSUNG SDI CO., LTD. (KR) 2011-05-17 US disclosed
US-7915455-B2 Transition metal complex ligand and olefin polymerization catalyst containing transition metal complex SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2011-03-29 US disclosed
US-4321339-A Fluorinated phenoxypropyl vinyl ether polymer E. I. DU PONT DE NEMOURS AND COMPANY (US) 1982-03-23 US disclosed
EP-0001825-B1 METHOD OF PREPARING 2,4-DIFLUOROANILINE MERCK & CO. INC. (US) 1982-01-13 EP disclosed
US-4294988-A Method of preparing 2,4-difluoroaniline MERCK & CO., INC. (US) 1981-10-13 US disclosed
US-4288574-A POST HYDROXYLATION E. I. DU PONT DE NEMOURS AND COMPANY (US) 1981-09-08 US disclosed
EP-0028161-A1 Fluorinated phenolic polymer and process for its preparation E.I. DU PONT DE NEMOURS AND COMPANY (US) 1981-05-06 EP disclosed
EP-0001825-A1 Method of preparing 2,4-difluoroaniline MERCK & CO. INC. (US) 1979-05-16 EP disclosed
US-4140719-A Solid-liquid phase transfer catalysis improved method of preparing 2,4-difluoroaniline MERCK & CO., INC. (US) 1979-02-20 US disclosed
US-4065259-A ONE STEP, SYNTHETIC POLYMERS E. I. DU PONT DE NEMOURS AND COMPANY (US) 1977-12-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030216598-A1 Method for producing tetrakis ( fluoroaryl) borate-magnesium compound KRAS, MGAM, CA3 KDM1A 4098/4885KDM1B 3691/4885CES2 3957/4885
US-20230265055-A1 STAT INIHIBITORY COMPOUNDS AND COMPOSITIONS STAT5B, STAT5A, STAT3 KDM1A 3048/4885KDM1B 2123/4885CES2 4732/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.